Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-14

Clinical Trial Update: The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and tolerability of Oleogel-S-10 in actinic keratosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oleogel-S-10

Snippet

Sponsor: Birken AG | Conditions: Actinic Keratoses | Phase 2 | Status: COMPLETED | Results posted: 2015-08-14